Cutting edge: Regulation of CD8+ T cell effector population size

Journal of Immunology

Volumn 173, Issue 5, 2004, Pages 2923-2927

  Kemp, Roslyn A ^a   Powell, Timothy J ^a   Dwyer, David W ^a   Dutton, Richard W ^a  

^a TRUDEAU INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; EFFECTOR CELL; IMMUNE RESPONSE; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TRANSGENE;

EID: 4344562815     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.5.2923     Document Type: Article

References (24)

1. + T cell priming by dendritic cells in intact lymph nodes. Nat. Immunol. 4:579.
2. + T cells. J. Immunol. 170:1822.
3. Kedl, R. M., W. A. Rees, D. A. Hildeman, B. Schaefer, T. Mitchell, J. Kappler, and P. Marrack. 2000. T cells compete for access to antigen-bearing antigen-presenting cells. J. Exp. Med. 192:1105.
4. Wolpert, E. Z., P. Grufman, J. K. Sandberg, A. Tegnesjo, and K. Karre. 1998. Immunodominance in the CTL response against minor histocompatibility antigens: interference between responding T cells, rather than with presentation of epitopes. J. Immunol. 161:4499.
5. Bullock, T. N. J., T. A. Colella, and V. H. Engelhard. 2000. The density of peptides displayed by dendritic cells affects immune responses to human tyrosinase and gp100 in HLA-A2 transgenic mice. J. Immunol. 164:2354.
6. Grufman, P., J. Sandberg, E. Wolpert, and K. Karre. 1999. Immunization with dendritic cells breaks immunodominance in CTL responses against minor histocompatibility and synthetic peptide antigens. J. Leukocyte Biol. 66:268.
7. Blattman, J. N., R. Antia, D. J. D. Sourdive, X. Wang, S. M. Kaech, K. Murali-Krishna, J. D. Altman, and R. Ahmed. 2002. Estimating the precursor frequency of naive antigen-specific CD8 T cells. J. Exp. Med. 195:657.
8. Pape, K., E. Kearney, A. Khoruts, A. Mondino, R. Merica, Z. Chen, E. Ingulli, J. White, J. Johnson, and M. Jenkins. 1997. Use of adoptive transfer of T-cell-antigen-receptor-transgenic T cell for the study of T-cell activation in vivo. Immunol. Rev. 156:67.
9. Hogquist, K., S. Jameson, W. Heath, J. Howard, M. Bevan, and F. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76:17.
10. + T cells mediate graft rejection via a distinct effector pathway. Nat. Immunol. 3:844.
11. + T cell-mediated spontaneous diabetes in neonatal mice. J. Immunol. 157:978.
12. Kemp, R. A., and F. Ronchese. 2001. Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity. J. Immunol. 167:6497.
13. Garrigan, K., P. Moroni-Rawson, C. McMurray, I. Hermans, N. Abernathy, J. Watson, and F. Ronchese. 1996. Functional comparison of spleen dendritic cells and dendritic cells cultured in vitro from bone marrow precursors. Blood 88:3508.
14. Hermans, I., A. Daish, P. Moroni-Rawson, and F. Ronchese. 1997. Tumor-peptide-pulsed dendritic cells isolated from spleen or cultured in vitro from bone marrow precursors can provide protection against tumor challenge. Cancer Immunol. Immunother. 44:341.
15. Roman, E., E. Miller, A. Harmsen, J. Wiley, U. H. von Andrian, G. Huston, and S. L. Swain. 2002. CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function. J. Exp. Med. 196:957.
16. Kedl, R., B. Schaefer, J. Kappler, and P. Marrack. 2002. T cells down-modulate peptide-MHC complexes on APCs in vivo. Nat. Immunol. 3:27.
17. McNally, J. M., C. C. Zarozinski, M.-Y. Lin, M. A. Brehm, H. D. Chen, and R. M. Welsh. 2001. Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses. J. Virol. 75:5965.
18. + T cells to antigen stimulation in vivo. Nat. Immunol. 1:47.
19. Zimmermann, C., A. Prevost-Blondel, C. Blaser, and H. Pircher. 1999. Kinetics of the response of naive and memory CD8 T cells to antigen: similarities and differences. Eur. J. Immunol. 29:284.
20. + T cell proliferation and effector function in vivo. Immunity 13:291.
21. Probst, H., T. Dumrese, and M. F. van den Broek. 2002. Competition for APC by CTLs of different specificities is not functionally important during induction of antiviral responses. J. Immunol. 168:5387.
22. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737.
23. + T cell responses. J. Exp. Med. 198:889.
24. + T cells restricted by the MHC class Ib molecule, Qa-1. Annu. Rev. Immunol. 18:185.